Literature DB >> 12045398

Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells.

Philip J Barter1, Paul W Baker, Kerry-Anne Rye.   

Abstract

There are several potential mechanisms by which HDLs protect against atherosclerosis. One relates to the ability of HDLs to promote the efflux of cholesterol from macrophages. Another is the ability of HDLs to inhibit one of the earliest events in the development of atherosclerosis, namely the expression of vascular cell adhesion molecules in activated endothelial cells. This property has been reported in vitro in studies with both native and reconstituted HDLs. The inhibitory activity of reconstituted HDLs is influenced by the phospholipid composition of the particles. An inhibition of endothelial cell adhesion molecule expression has also been observed in some (but not all) studies conducted in vivo in mice and pigs. The mechanism of this potentially anti-atherogenic effect of HDLs remains uncertain, as does its contribution to the cardioprotective effects of HDLs in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045398     DOI: 10.1097/00041433-200206000-00008

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  34 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.

Authors:  Wilissa D'Souza; John A Stonik; Andrew Murphy; Steven J Demosky; Amar A Sethi; Xiao L Moore; Jaye Chin-Dusting; Alan T Remaley; Dmitri Sviridov
Journal:  Circ Res       Date:  2010-05-27       Impact factor: 17.367

Review 3.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

Review 4.  Obesity and lipids.

Authors:  Wendy M Miller; Katherine E Nori-Janosz; Martin Lillystone; Jose Yanez; Peter A McCullough
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

Review 5.  HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease.

Authors:  H Bryan Brewer
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

Review 6.  Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

Authors:  Emil M deGoma; Rolando L deGoma; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

Review 7.  Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.

Authors:  Mohammed M Al Gadban; Mohamed M Alwan; Kent J Smith; Samar M Hammad
Journal:  Clin Immunol       Date:  2015-01-28       Impact factor: 3.969

8.  Coronary artery diseases in South Asian immigrants: an update on high density lipoprotein role in disease prevention.

Authors:  Sunita Dodani
Journal:  J Immigr Minor Health       Date:  2008-09-24

9.  Atherothrombosis in South asians: implications of atherosclerotic and inflammatory markers.

Authors:  Sunita Dodani
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

10.  Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study.

Authors:  Raghava S Velagaleti; Joseph Massaro; Ramachandran S Vasan; Sander J Robins; William B Kannel; Daniel Levy
Journal:  Circulation       Date:  2009-11-23       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.